University of Melbourne

Synchron is a medical technology company focused on developing innovative brain-computer interface solutions. It manufactures an implantable device known as the stentrode, which is delivered to the brain via a catheter. This minimally invasive device is embedded with electrode arrays that can interpret neuronal signals and modulate neural activity in targeted areas. By enabling patients with motor impairments to control digital devices, prosthetics, and other assistive technologies through thought, Synchron aims to enhance the quality of life for individuals with disabilities.

Tiny Bright Things is a Melbourne-based company founded in 2020 by Ray Dagastine and Chris Bolton, specializing in innovative microscopy technology known as Halo microscopy. This technology significantly enhances the imaging and measurement of small or transparent objects, catering to the needs of industrial manufacturers and researchers across various fields. In particular, it serves sectors such as agrichemicals and pharmaceuticals, where the size and shape of powders are crucial. Additionally, the technology is instrumental in nanotechnology and life sciences, enabling accurate analysis of samples that are often tiny or transparent. By allowing imaging and measurement down to the scale of viruses, drug particles, and nanotubes without altering the samples, Tiny Bright Things supports effective research and development at various stages of discovery.

Proudly partnered with The University of Melbourne and the Australian Research Council, AIBUILD is a big data and innovative solutions provider founded in 2017 as an emerging Australian startup. AIBUILD positions itself as a professional industry innovative solutions provider. Over the last three years in Australia, we have developed big data and software solutions for clients in industries ranging from the real estate industry to education and research, including: JH Market - Multi-warehouse solutions + distributed system for large industrial electrical products supplier (JinHang Lighting & Electrical) MyMart – Innovative e-commerce + smart supply chain solution for large Asian groceries (KT Mart) HousePro – Innovative real-time VR+AI matching system in global real-estate industry Crowdfunding platform - ARC IH150100006 (The University of Melbourne, Monash University, Australian Research Council) Otaro - Real-time online panorama/VR teaching platform (The University of Melbourne) A smart wind-driven natural ventilation system for buildings (The University of Melbourne, RMIT) We aim to ensure the widespread use of Artificial Intelligence Technology in Australia by helping our enterprise clients reduce costs and Improve consistency in their processes with Artificial Intelligence (AI) and virtual reality (VR) technology. We remain firmly committed to providing unparalleled quality design and impeccable service to ensure we meet the ranging needs of all our customers.

Synchron is a medical technology company focused on developing innovative brain-computer interface solutions. It manufactures an implantable device known as the stentrode, which is delivered to the brain via a catheter. This minimally invasive device is embedded with electrode arrays that can interpret neuronal signals and modulate neural activity in targeted areas. By enabling patients with motor impairments to control digital devices, prosthetics, and other assistive technologies through thought, Synchron aims to enhance the quality of life for individuals with disabilities.

Proudly partnered with The University of Melbourne and the Australian Research Council, AIBUILD is a big data and innovative solutions provider founded in 2017 as an emerging Australian startup. AIBUILD positions itself as a professional industry innovative solutions provider. Over the last three years in Australia, we have developed big data and software solutions for clients in industries ranging from the real estate industry to education and research, including: JH Market - Multi-warehouse solutions + distributed system for large industrial electrical products supplier (JinHang Lighting & Electrical) MyMart – Innovative e-commerce + smart supply chain solution for large Asian groceries (KT Mart) HousePro – Innovative real-time VR+AI matching system in global real-estate industry Crowdfunding platform - ARC IH150100006 (The University of Melbourne, Monash University, Australian Research Council) Otaro - Real-time online panorama/VR teaching platform (The University of Melbourne) A smart wind-driven natural ventilation system for buildings (The University of Melbourne, RMIT) We aim to ensure the widespread use of Artificial Intelligence Technology in Australia by helping our enterprise clients reduce costs and Improve consistency in their processes with Artificial Intelligence (AI) and virtual reality (VR) technology. We remain firmly committed to providing unparalleled quality design and impeccable service to ensure we meet the ranging needs of all our customers.

Apromore is a platform that specializes in process mining solutions aimed at enhancing operational efficiency and effectiveness for organizations. By utilizing data from various enterprise systems, Apromore allows business teams to visualize, analyze, and improve their existing processes. The platform combines process mining capabilities with an intuitive design and extensive data connectivity, facilitating the identification of inefficiencies, friction points, and compliance violations. This enables organizations to leverage advanced data science techniques in a no-code environment, promoting digital transparency and operational excellence. With a focus on delivering actionable insights, Apromore supports teams in making informed decisions that lead to improved customer experiences and better risk management.

Denteric is focused on developing vaccines to combat periodontal diseases, leveraging research from the University of Melbourne and collaboration with CSL Limited. The company's biotechnology platform targets the virulence factors produced by the bacterium Porphyromonas gingivalis and related species, which are known to cause various dental diseases and their complications. By creating these vaccines, Denteric aims to provide effective treatments for patients suffering from dental issues, improving their overall oral health. The company has secured funding that is distributed in three parts annually from 2019 to 2021, supporting its ongoing research and development efforts.

Tiny Bright Things is a Melbourne-based company founded in 2020 by Ray Dagastine and Chris Bolton, specializing in innovative microscopy technology known as Halo microscopy. This technology significantly enhances the imaging and measurement of small or transparent objects, catering to the needs of industrial manufacturers and researchers across various fields. In particular, it serves sectors such as agrichemicals and pharmaceuticals, where the size and shape of powders are crucial. Additionally, the technology is instrumental in nanotechnology and life sciences, enabling accurate analysis of samples that are often tiny or transparent. By allowing imaging and measurement down to the scale of viruses, drug particles, and nanotubes without altering the samples, Tiny Bright Things supports effective research and development at various stages of discovery.

Certa Therapeutics, established in 2017 and headquartered in Melbourne, Australia, is a biotechnology company specializing in the development of precision medicines for fibrotic diseases, with a primary focus on kidney disorders. The company employs genetic analysis to identify patients at risk of developing kidney fibrosis, a precursor to end-stage kidney failure. Certa's drug pipeline targets a key receptor driving kidney fibrosis, aiming to halt or reverse the scarring process and prevent the need for dialysis or transplantation. Currently in the clinical stage, the company's mission is to transform the treatment landscape for fibrotic diseases by enabling early intervention and improving patient outcomes.

Clarity Pharmaceuticals is a clinical-stage company specializing in personalized medicine through innovative radiopharmaceutical technology. The company focuses on developing next-generation theranostic products that combine therapy and imaging, utilizing its proprietary SAR Technology. This platform is particularly effective with copper isotopes, enhancing the imaging and therapeutic capabilities of radiopharmaceuticals while addressing existing manufacturing and logistical challenges in oncology. Clarity's approach enables the radiolabeling of antibodies, which can be visualized using PET imaging. The resulting human imaging data helps determine whether a drug successfully targets a disease in individual patients, allowing for a tailored treatment strategy that optimizes patient outcomes by treating only those likely to respond to therapy.

Hatchtech is an Australian company focused on developing innovative pest control solutions through its proprietary technology platform. The company's patented approach targets the egg hatch of pest species, effectively disrupting their lifecycle with a novel mode of action. Hatchtech's technology is designed to address various invertebrate pests, including ectoparasites such as head lice, as well as pests affecting animals, crops, and the built environment. Their flagship product offers a single-dose treatment that eliminates both head lice and their eggs in one application, providing an effective solution for infestations.

Omny Studio is a comprehensive on-demand audio management solution designed for content creators, including radio stations and podcasters. The platform facilitates the distribution, analysis, monetization, and archiving of audio content, enabling users to focus on producing high-quality material for their audiences. By offering seamless integration with live streaming services, content management systems, and advertising platforms, Omny Studio streamlines the audio publishing workflow. This software-as-a-service solution helps creators grow their audience while reducing production costs, ultimately enhancing their ability to monetize their content effectively.